Special Issue "Antimicrobial Properties of Nanoparticle"

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Antimicrobial Agents and Resistance".

Deadline for manuscript submissions: 31 October 2023 | Viewed by 946

Special Issue Editors

Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
Interests: peptides; anti-viral peptide; anti-bacterial peptide
Special Issues, Collections and Topics in MDPI journals
Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
Interests: herpesvirus; antimicrobial peptides; antiviral; coronavirus; viral infections; natural products
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Emerging and re-emerging pathogens together with drug-resistant microbes pose significant global health challenges. The continuous and complex interchange between environment, animal world, human habits and pathogens represent a growing problem in the treatment of infectious diseases. The scientific explorations of nanoparticles for their inherent therapeutic potencies as antimicrobial and antiviral agents also due to increasing incidences of antibiotic resistance have gained more attention in recent time. The popularity of nanotechnology results from the possibility of obtaining materials that have better chemical, electrical, thermal, mechanical, or optical properties. Nano-sized materials are characterized by an increased surface area to volume ratio, which improves their chemical reactivity. Several investigations have demonstrated the potential of nanoparticles in the treatment of various microbial infections. The therapeutic applications of nanoparticles as either delivery agents or broad spectrum inhibitory agents against viral and microbial infections are ready to be fully exploited.

The broad spectrum antimicrobial activity of nanoparticles is exerted through multifaceted mechanisms. The adhesion of nanoparticles to microbial cells, production of reactive oxygen species, and their penetration inside the cells, have been recognized as the most prominent modes of antimicrobial action. 

The present Special Issue focuses on the antibacterial, antiviral, antifungal, and antiparasitic potential of nanoparticles and the analysis of their mechanisms of action. The emerging efforts to address current challenges and solutions for the production of nanoparticles and the treatment of infectious diseases will also be considered. We invite authors to submit original or review articles covering all aspects of this topic.

Prof. Massimiliano Galdiero
Dr. Carla Zannella
Dr. Annalisa Chianese
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanoparticles
  • nanomaterials
  • antiviral
  • antimicrobial
  • drug-delivery

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Article
Synergistic Anticandidal Effectiveness of Greenly Synthesized Zinc Oxide Nanoparticles with Antifungal Agents against Nosocomial Candidal Pathogens
Microorganisms 2023, 11(8), 1957; https://doi.org/10.3390/microorganisms11081957 - 31 Jul 2023
Viewed by 673
Abstract
The high prevalence of fungal resistance to antifungal drugs necessitates finding new antifungal combinations to boost the antifungal bioactivity of these agents. Hence, the aim of the present investigation was to greenly synthesize zinc oxide nanoparticles (ZnO-NPs) using an aqueous leaf extract of [...] Read more.
The high prevalence of fungal resistance to antifungal drugs necessitates finding new antifungal combinations to boost the antifungal bioactivity of these agents. Hence, the aim of the present investigation was to greenly synthesize zinc oxide nanoparticles (ZnO-NPs) using an aqueous leaf extract of Salvia officinalis and investigate their antifungal activity and synergistic efficiency with common antifungal agents. The biofabricated ZnO-NPs were characterized to detect their physicochemical properties. A disk diffusion assay was employed to investigate the antifungal effectiveness of the greenly synthesized ZnO-NPs and evaluate their synergistic patterns with common antifungal agents. The Candida tropicalis strain was detected to be the most susceptible strain to ZnO-NPs at both tested concentrations of 50 and 100 µg/disk, demonstrating relative suppressive zones of 19.68 ± 0.32 and 23.17 ± 0.45 mm, respectively. The minimum inhibitory concentration (MIC) of ZnO-NPs against the C. tropicalis strain was 40 µg/mL, whereas the minimum fungicidal concentration (MFC) was found to be 80 µg/mL. The highest synergistic efficiency of the biogenic ZnO-NPs with terbinafine antifungal agent was detected against the C. glabrata strain, whereas the highest synergistic efficiency was detected with fluconazole against the C. albicans strain, demonstrating relative increases in fold of inhibition area (IFA) values of 6.82 and 1.63, respectively. Moreover, potential synergistic efficiency was detected with the nystatin antifungal agent against the C. tropicalis strain with a relative IFA value of 1.06. The scanning electron microscopy (SEM) analysis affirmed the morphological deformations of candidal cells treated with the biosynthesized ZnO-NPs as the formation of abnormal infoldings of the cell wall and membranes and also the formation of pores in the cell wall and membranes, which might lead to the leakage of intracellular constituents. In conclusion, the potential synergistic efficiency of the biogenic ZnO-NPs with terbinafine, nystatin, and fluconazole against the tested candidal strains highlights the potential application of these combinations in formulating novel antifungal agents of high antimicrobial efficiency. The biogenic ZnO nanoparticles and antifungal drugs exhibit powerful synergistic efficiency, which highlights their prospective use in the formulation of efficient antimicrobial medications, including mouthwash, ointments, lotions, and creams for effective candidiasis treatment. Full article
(This article belongs to the Special Issue Antimicrobial Properties of Nanoparticle)
Show Figures

Figure 1

Back to TopTop